Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
197.2 EUR | +0.18% | -1.13% | -7.24% |
13/06 | Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270 | MT |
07/06 | The job report just threw a spanner in the works |
Chart calendar Charles River Laboratories International, Inc.
Upcoming events on Charles River Laboratories International, Inc.
Past events on Charles River Laboratories International, Inc.
05/06/2024 07:30 pm | Jefferies Global Healthcare Conference |
04/06/2024 08:30 pm | William Blair Growth Stock Conference |
09/05/2024 06:00 pm | Q1 2024 Earnings Call |
09/05/2024 04:30 pm | Q1 2024 Earnings Release |
08/05/2024 05:30 pm | Annual General Meeting |
10/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:6181 |
10/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:5467 |
10/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:5315 |
09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:4703 |
09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:4413 |
09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:4224 |
09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:4191 |
09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:4186 |
09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:4182 |
09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Poster No:3975 |
09/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:2841 |
09/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:2840 |
09/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:2835 |
09/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:2714 |
09/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster No:2630 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 621 2 614 0.28% | 2 924 2 891 1.15% | 3 540 3 522 0.52% | 3 976 3 915 1.56% | 4 129 4 107 0.54% | 4 221 |
EBITDA Million USD | Released Forecast Spread | 604 597 1.28% | 701 693 1.26% | 879 878 0.22% | 991 982 0.87% | 1 013 1 017 -0.4% | 1 063 |
EBIT Million USD | Released Forecast Spread | 497 489 1.64% | 585 575 1.73% | 742 738 0.51% | 834 820 1.67% | 839 842 -0.35% | 870 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 304 284 7.16% | 447 394 13.45% | 481 449 7.01% | 623 568 9.63% | 581 513 13.41% | 534 |
Net income Million USD | Released Forecast Spread | 252 240 4.84% | 364 296 23% | 391 358 9.2% | 486 409 18.85% | 475 387 22.66% | 410 |
EPS USD | Released Forecast Spread | 5,07 4,85 4.57% | 7,20 5,88 22.44% | 7,60 6,99 8.67% | 9,48 7,97 18.98% | 9,22 7,49 23.07% | 7,95 |
Announcement Date | 11/02/20 | 17/02/21 | 16/02/22 | 22/02/23 | 14/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 914 909 0.58% | 973 995 -2.22% | 989 970 1.93% | 1 100 1 035 6.26% | 1 029 986 4.39% | 1 060 1 054 0.59% | 1 027 1 000 2.61% | 1 013 991 2.24% | 1 012 993 1.82% | 1 022 | 1 071 | 1 113 | 1 095 | 1 105 |
EBITDA Million USD | Released Forecast Spread | 233 233 0.02% | 250 247 1.36% | 240 238 1.14% | 267 260 2.72% | 260 252 3.03% | 260 258 0.62% | 255 241 5.8% | 239 242 -1.38% | 233 222 4.94% | 243 | 285 | 304 | 263 | 269 |
EBIT Million USD | Released Forecast Spread | 196 194 1.26% | 212 208 1.97% | 201 197 2.26% | 225 213 5.33% | 218 209 3.98% | 216 213 1.41% | 211 194 8.51% | 194 196 -1% | 187 178 5.43% | 196 | 238 | 255 | 228 | 234 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 111 149 -25.64% | 144 142 1.83% | 123 128 -3.67% | 245 155 57.85% | 131 150 -12.47% | 129 143 -10.32% | 113 120 -6.11% | 209 120 74.62% | 99,0 96,3 2.82% | 110 | 156 | 169 | 150 | 157 |
Net income Million USD | Released Forecast Spread | 93,0 109 -14.63% | 109 110 -0.34% | 96,5 98,4 -1.95% | 187 109 71.19% | 103 102 0.7% | 97,0 105 -7.26% | 87,4 88,9 -1.74% | 187 92,4 102.53% | 67,3 71,2 -5.45% | 83,6 | 122 | 131 | 117 | 117 |
EPS USD | Released Forecast Spread | 1,81 2,07 -12.39% | 2,13 2,13 -0.04% | 1,88 1,84 2.12% | 3,65 2,14 70.86% | 2,01 1,99 0.87% | 1,89 2,04 -7.23% | 1,69 1,68 0.51% | 3,62 1,78 103.94% | 1,30 1,35 -3.7% | 1,68 | 2,32 | 2,58 | 2,16 | 2,21 |
Announcement Date | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 11/05/23 | 09/08/23 | 08/11/23 | 14/02/24 | 09/05/24 | - | - | - | - | - |
15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Charles River Laboratories International, Inc.
30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
15/05/2024 01:35 am | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRL Stock
- RV6 Stock
- Calendar Charles River Laboratories International, Inc.